A detailed history of Gps Wealth Strategies Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Gps Wealth Strategies Group, LLC holds 1,385 shares of AMGN stock, worth $378,672. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,385
Previous 1,419 2.4%
Holding current value
$378,672
Previous $443,000 0.68%
% of portfolio
0.06%
Previous 0.07%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$309.38 - $337.38 $10,518 - $11,470
-34 Reduced 2.4%
1,385 $446,000
Q2 2024

Jul 16, 2024

SELL
$262.75 - $319.31 $762,763 - $926,956
-2,903 Reduced 67.17%
1,419 $443,000
Q1 2024

Apr 30, 2024

SELL
$268.87 - $324.56 $9,679 - $11,684
-36 Reduced 0.83%
4,322 $1.23 Million
Q4 2023

Jan 12, 2024

SELL
$255.7 - $288.46 $28,382 - $32,019
-111 Reduced 2.48%
4,358 $1.26 Million
Q3 2023

Oct 25, 2023

BUY
$218.65 - $271.46 $633,647 - $786,691
2,898 Added 184.47%
4,469 $1.2 Million
Q2 2023

Jul 17, 2023

BUY
$214.27 - $253.37 $51,639 - $61,062
241 Added 18.12%
1,571 $348,000
Q1 2023

Apr 17, 2023

BUY
$225.79 - $275.2 $300,300 - $366,016
1,330 New
1,330 $321,000
Q3 2022

Oct 17, 2022

BUY
$224.46 - $253.15 $55,666 - $62,781
248 Added 31.08%
1,046 $236,000
Q2 2022

Jul 19, 2022

BUY
$230.71 - $256.74 $23,993 - $26,700
104 Added 14.99%
798 $194,000
Q1 2022

Apr 20, 2022

BUY
$219.27 - $242.57 $1,534 - $1,697
7 Added 1.02%
694 $168,000
Q4 2021

Feb 11, 2022

BUY
$198.88 - $227.6 $16,109 - $18,435
81 Added 13.37%
687 $155,000
Q3 2021

Oct 20, 2021

SELL
$212.27 - $248.7 $43,515 - $50,983
-205 Reduced 25.28%
606 $129,000
Q2 2021

Jul 19, 2021

BUY
$233.58 - $259.14 $6,306 - $6,996
27 Added 3.44%
811 $198,000
Q1 2021

Apr 15, 2021

BUY
$221.91 - $258.6 $173,977 - $202,742
784 New
784 $195,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $146B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Gps Wealth Strategies Group, LLC Portfolio

Follow Gps Wealth Strategies Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gps Wealth Strategies Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gps Wealth Strategies Group, LLC with notifications on news.